ArticleJACC. Case reports2026
From Shoulder to Heart: Acute Shoulder Pain Leads to a Diagnosis of Fabry Disease.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFabry disease (FD) is an X-linked lysosomal storage disorder caused by a mutation in the GLA gene. The classic phenotype primarily affects male children with progressive multiorgan complications, while the atypical phenotype presents with predominant cardiac and renal manifestations in midlife. CASE SUMMARY: A 49-year-old man presented with acute left shoulder pain and abnormal electrocardiographic findings. Subsequent evaluation revealed persistent mild troponin elevation, left ventricular hypertrophy, and reduced native T1-relaxation time on cardiac magnetic resonance imaging. Severely reduced serum α-galactosidase level confirmed FD. Migalastat therapy was initiated, with no disease progression at most recent follow-up. DISCUSSION: Identification of late-onset FD requires a high index of suspicion, multimodal cardiac imaging, and genetic testing. Management requires a multidisciplinary approach to monitor and prevent disease progression. TAKE-HOME MESSAGES: Unexplained chronic troponin elevation and left ventricular hypertrophy merit further evaluation, even if the abnormality is mild. Diagnostic work-up for FD involves cardiac magnetic resonance imaging, serum α-galactosidase level, and genetic testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.